The IBN SINA Pharmaceutical Industry PLC (DSE: IBNSINA)

IBNSINA Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 13, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	9,117	7,805	8,954	9,270	7,708	7,002
Market Cap Growth	-12.84%	-12.84%	-3.40%	20.27%	10.08%	-15.15%
Enterprise Value	10,648	8,919	9,692	9,892	8,398	7,847
Last Close Price	291.80	244.69	274.85	278.97	228.05	203.91
PE Ratio	13.60	11.40	14.18	14.39	14.57	16.23
PS Ratio	0.80	0.69	0.98	1.09	1.04	1.13
PB Ratio	2.61	2.21	2.93	3.53	3.59	3.94
P/TBV Ratio	2.23	2.23	2.96	3.56	3.59	3.94
P/FCF Ratio	-	-	18.93	173.59	24.89	-
P/OCF Ratio	17.78	17.78	9.97	22.15	13.96	14.07
EV/Sales Ratio	0.94	0.78	1.06	1.17	1.14	1.27
EV/EBITDA Ratio	5.99	5.09	6.22	9.69	9.11	10.52
EV/EBIT Ratio	11.64	9.75	11.82	12.05	11.46	13.09
EV/FCF Ratio	-60.98	-	20.49	185.25	27.12	-
Debt / Equity Ratio	0.53	0.53	0.32	0.41	0.40	0.54
Debt / EBITDA Ratio	1.06	1.06	0.62	1.02	0.91	1.25
Debt / FCF Ratio	-	-	2.09	20.02	2.80	-
Asset Turnover	1.98	1.98	1.96	2.08	2.03	1.98
Inventory Turnover	4.99	4.99	4.86	5.49	6.00	6.17
Quick Ratio	0.24	0.24	0.23	0.35	0.27	0.17
Current Ratio	1.13	1.13	1.26	1.46	1.26	0.83
Return on Equity (ROE)	20.38%	20.38%	21.33%	25.37%	24.91%	24.12%
Return on Assets (ROA)	9.93%	9.93%	11.00%	12.59%	12.58%	11.96%
Return on Capital (ROIC)	12.08%	12.08%	13.24%	15.30%	15.90%	15.24%
Earnings Yield	7.35%	8.59%	6.76%	6.54%	6.35%	5.61%
FCF Yield	-1.92%	-2.24%	5.28%	0.58%	4.02%	-1.64%
Dividend Yield	2.16%	2.57%	2.18%	2.15%	2.06%	1.89%
Payout Ratio	26.83%	26.83%	29.49%	29.28%	26.89%	22.16%
Total Shareholder Return	2.16%	2.57%	2.18%	2.15%	2.06%	1.89%

Source: S&P Capital IQ. Standard template. Financial Sources.